QUILL POLYPROPYLENE KNOTLESS TISSUE-CLOSURE DEVICE, VARIABLE LOOP DESIGN

K130078 · Surgical Specialties Corp. Dba Angiotech · GAW · Feb 28, 2013 · General, Plastic Surgery

Device Facts

Record IDK130078
Device NameQUILL POLYPROPYLENE KNOTLESS TISSUE-CLOSURE DEVICE, VARIABLE LOOP DESIGN
ApplicantSurgical Specialties Corp. Dba Angiotech
Product CodeGAW · General, Plastic Surgery
Decision DateFeb 28, 2013
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.5010
Device ClassClass 2
AttributesTherapeutic

Intended Use

Quill™ Knotless Tissue-Closure Device comprised of Polypropylene is indicated for soft tissue approximation excluding closure of the epidermis.

Device Story

Quill™ Polypropylene Knotless Tissue-Closure Device is a sterile, synthetic, nonabsorbable surgical suture. Device consists of high molecular weight, isotactic polypropylene monofilament featuring uni-directional barbs along its long axis to facilitate tissue anchoring without knots. Distal end incorporates a welded primary and secondary loop design. Used by surgeons for soft tissue approximation; excludes epidermal closure. Device provides mechanical tension to hold tissue edges together during healing. Benefits include elimination of knot-tying, potentially reducing procedure time and improving tension distribution across the wound.

Clinical Evidence

Bench testing only. Testing conducted to confirm conformance to USP monograph for nonabsorbable sutures regarding tensile strength and needle attachment, per FDA's Class II Special Controls Guidance Document: Surgical Sutures (2003).

Technological Characteristics

Material: High molecular weight, isotactic polypropylene (undyed or dyed with Phthalocyaninato (2-) Copper). Design: Monofilament with uni-directional barbs and welded primary/secondary loop at distal end. Form factor: Size 0, various lengths and needle types. Nonabsorbable. Sterilization: Sterile.

Indications for Use

Indicated for soft tissue approximation in patients requiring surgical closure, excluding closure of the epidermis.

Regulatory Classification

Identification

Nonabsorbable polypropylene surgical suture is a monofilament, nonabsorbable, sterile, flexible thread prepared from long-chain polyolefin polymer known as polypropylene and is indicated for use in soft tissue approximation. The polypropylene surgical suture meets United States Pharmacopeia (U.S.P.) requirements as described in the U.S.P. Monograph for Nonabsorbable Surgical Sutures; it may be undyed or dyed with an FDA approved color additive; and the suture may be provided with or without a standard needle attached.

Special Controls

*Classification.* Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K130078 pa · page 1/2 . . Section 5 - 510(k) Summary control concession in the consideration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . | Date Prepared: | January 9, 2013 | FEB 2 8 2013 | |------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------| | Company: | Angiotech | | | | 100 Dennis Dr. | | | | Reading, PA 19606 | | | Contact: | Kirsten Stowell | | | | Regulatory Affairs Manager | | | | Phone: | 610-404-3367 | | | Fax: | 610-404-3924 | | | Email: | kstowell@angio.com | | Device trade name: | Quill™ Polypropylene Knotless-Tissue Closure Device, Variable<br>Loop Design | | | Device Common<br>Name: | Nonabsorbable polypropylene surgical suture | | | Device classification: | Nonabsorbable polypropylene surgical suture | | | | Product code, GAW | | | | 21 CFR 878.5010 | | | | Class II | | | Legally marketed<br>devices to which the<br>device is substantially<br>equivalent: | K052373 | Quill™ Nonabsorbable Polypropylene Barbed<br>Suture | | | K113744: | Quill™ PDO Knotless Tissue-Closure Device<br>(Polydioxanone), Variable Loop Design | | | K123409: | Quill™ Monoderm™ Knotless Tissue-Closure<br>Device, Variable Loop Design | | Description of the<br>device: | The Quill™ Polypropylene Knotless Tissue-Closure Device,<br>Variable Loop Design is a sterile, synthetic nonabsorbable tissue-<br>closure device that is intended for use in the closure of soft tissue,<br>excluding closure of the epidermis. It is comprised of high<br>molecular weight, isotactic polypropylene, undyed, or dyed blue<br>with Phthalocyaninato (2-) Copper. The device is designed with<br>small uni-directional barbs along the long axis of the suture<br>monofilament which contains a welded primary loop and<br>secondary loop design at the distal end. It is available in diameter<br>Size 0 in various lengths affixed to various needle types. | | ・ . . . . . . · {1}------------------------------------------------ K130078 page 2/2 Indications for Use: Substantial Equivalence: Performance tests: Quill™ Knotless Tissue-Closure Device comprised of Polypropylene is indicated for soft tissue approximation excluding closure of the epidermis. The QuillTM Polypropylene Knotless Tissue-Closure device, Variable Loop Design is identical in material composition and intended use to the QuillTM Polypropylene Barbed Suture predicate. The proposed device is identical in design to the QuillTM PDO and QuillTM Monoderm™ Knotless Tissue-Closure Device, Variable Loop Design predicate devices. Non-clinical laboratory performance testing was conducted to confirm that the Quill™ Polypropylene Knotless Tissue-Closure device, Variable Loop Design, conforms to the USP monograph for nonabsorbable sutures for tensile strength (as applicable) and needle attachment. This testing was performed in accordance with FDA's Class II Special Controls Guidance Document: Surgical Sutures, Issued June 3, 2003. The results of this testing demonstrates that the QuillTM Polypropylene Knotless Tissue-Closure device, Variable Loop Design, is substantially equivalent to the predicate devices. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird with three stylized wing-like shapes. ## DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Surgical Specialties Corporation, DBA Angiotech % Ms. Kirsten Stowell Regulatory Affairs Manager 100 Dennis Drive Reading, Pennsylvania 19606 February 28, 2013 Re: K130078 Trade/Device Name: Quill™ Polypropylene Knotless Tissue-Closure Device, Variable Loop Design Regulation Number: 21 CFR 878.5010 Regulation Name: Nonabsorbable poly-propylene surgical suture Regulatory Class: Class II Product Code: GAW Dated: January 09, 2013 Received: January 15, 2013 Dear Ms. Stowell: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical {3}------------------------------------------------ Page 2 - Ms. Kirsten Stowell device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, . FOR PeterDA Rumm-S Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Section 4 - Indications for Use Statement K130078 510k number if known: Quill™ Polypropylene Knotless Tissue-Closure Device, Variable Loop Device Name: Design Indications for Use: Quill™ Knotless Tissue-Closure Device comprised of Polypropylene is indicated for soft tissue approximation excluding closure of the epidermis. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ## David Krauses (Division Sign-Off) Division of Surgical Devices 510(k) Number: K130078
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%